Bone marrow adipocytes (BMAds) are situated within the bone microenvironment, in close proximity to bone cells, vascular structures, and hematopoietic tissues. The shift of bone marrow stromal/stem cells (BMSCs) lineage towards committed adipogenic progenitors at the expense of osteoprogenitors is driven by abnormal signaling within the bone microenvironment due to pathophysiological conditions.
However, the precise mechanisms underlying excessive BMAds, particularly in response to pathophysiological conditions, in mediating cellular communication among bone-resident cells remain unclear.
Recently, a research team has revealed that the absence of estrogen-related receptor α (ESRRA) in adipocytes, leads to changes in the expression of secreted factors that have synergistic effects on BMSCs fate determination and vascular endothelial cells angiogenesis. These indicate that targeting ESRRA in adipocytes could be a potential therapeutic target for osteoporosis.
The study was published in Nature Communications.
In this study, researchers found that adipocyte-specific ESRRA knockout rescues bone loss and type H vessel distortion, as well as inhibits marrow adiposity in mice induced by ovariectomy (OVX) or diet-induced obesity (DIO).
Experimental results showed that adipocyte ESRRA interferes with the signaling of 17-estradiol and estrogen receptor alpha, resulting in the transcriptional repression of secreted phosphoprotein 1 (Spp1). Consequently, the release of SPP1 from ESRRA-deficient adipocytes enhances endothelial cells migration and restores type H vessels formation in mice induced by OVX or DIO.
Additionally, ESRRA positively modulates leptin expression by binding to its promoter. Consequently, ESRRA abrogation decreased the secretion of leptin from both visceral adipocytes and BMAds, promoting BMSCs to differentiate into osteoblasts rather than adipocytes.
Moreover, pharmacological inhibition of ESRRA significantly restricted marrow adipose tissue expansion and promoted bone formation in an adipocyte-rich bone milieu of obese mice, thereby preventing bone loss and high marrow adiposity.
This study provides a new method for treating bone disorders especially in clinical conditions associated with high marrow adiposity by targeting ESRRA.
Latest News
Pan-cancer proteogenomics e…
By newseditor
Posted 05 Jul
Fertility treatments could…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
How an unstructured protein…
By newseditor
Posted 04 Jul
Precise control of endogeno…
By newseditor
Posted 04 Jul
Other Top Stories
Mechanism of hypoxia sensing in the brain
Read more
Single cell RNA sequencing uncovers new mechanisms of heart disease
Read more
Exercise Increases Dopamine Release in Mice
Read more
Antiaging effect of FGF21 in low protein diet
Read more
Genetic study identifies link between blood proteins and migraine
Read more
Protocols
Pan-cancer proteogenomics c…
By newseditor
Posted 05 Jul
A systems biology-based ide…
By newseditor
Posted 05 Jul
Tongue orthotopic xenograft…
By newseditor
Posted 04 Jul
Monitoring norepinephrine r…
By newseditor
Posted 01 Jul
BicemuS: A new tool for neu…
By newseditor
Posted 26 Jun
Publications
Prevention of Falls in Olde…
By newseditor
Posted 05 Jul
The primitive endoderm supp…
By newseditor
Posted 05 Jul
Migrasome biogenesis: when…
By newseditor
Posted 05 Jul
Extended-release ketamine t…
By newseditor
Posted 05 Jul
Regulation of stress-induce…
By newseditor
Posted 04 Jul
Presentations
Myelin plasticity in the ve…
By newseditor
Posted 10 Jun
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar